Position in RPRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,134,313
+$735,813 QoQ
Shares Held
55,900
+11.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#237
of 641 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cumberland Partners Ltd holds $7,290,948 across 2 Biotechnology names. RPRX ranks #2 (43.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,368 | $4,156,635 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
55,900 | $3,134,313 |
All Filings in RPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,134,313 | 55,900 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,398,500 | 50,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,352,400 | 35,000 | Shares | Defined | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||